|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Time for new indications for statins显示文摘 | BANACH M MIKHAILIDIS D P KJELDSEN S E | 2009 | Med Sci Monit2009，15，12： | 1 |
| 2 | Left atrial size inhypertension and stroke显示文摘 | Piotrowski G Banach M Gerdts E | 2011 | J Hypertens2011，29，10： | 1 |
| 3 | A Multifaceted Approach to Hydrogen Storage显示文摘 | Churchard A J Banach E Borgschuhe A | 2011 | Phys Chem Chem Phys2011，13，16： | 1 |
| 4 | Cobalt cationic sites in ferrierites: QM / MM modeling显示文摘 | BANACH E KOZYRA P REJMAK P BROCLAWIK E DATKA J | 2008 | CatalToday2008，137，2： | 1 |
| 5 | Melatonin in experimental seizures and epilepsy显示文摘 | BANACH M GURDZIEL E JEDRYCH M | 2011 | Pharmacol Rep2011，63，1： | 1 |
| 6 | Localized mucosal response to intranasal live attenuated influenza vaccine in adults显示文摘 | Barria MI Garrido JL Stein C Scher E Ge Y Engel SM Kraus TA Banach D Moran TM | 2013 | J Infect Dis2013，207，1： | 1 |
| 7 | New cata- lyst fot poly (butylene terephthalate) synthesis 1 titanium- lanthanides and titanium-hafnium systems 显示文摘 | BANACH T E BERTI C COLONNA M | 2001 | Polymer2001，42，： | 1 |
| 8 | Left atrial size in hypertension and stroke 显示文摘 | Piotrowski G Banach'M Gerdts E | 2011 | J Hypertens2011，29，10： | 1 |
| 9 | Effectiveness of the National Population-Based Cervical Cancer Screening Programme in Poland- Out- comes, problems and possible solutions 7 years after im- plementation显示文摘 | Januszek-Michalecka L Nowak-Markwitz E Banach P | 2013 | Ann Agric Environ Med2013，20，4： | 1 |
| 10 | Matrix metallo- proteinases in type 2 diabetes and non-diabetic controls:effects of short-term and chronic hyperglycaemia显示文摘 | Lewandowski KC Banach E Bienkiewicz M | 2011 | Arch Med Sci2011，7，2： | 1 |
| 11 | Left atrial size in hypertension and stroke显示文摘 | Piotrowski G Banach M Gerdts E | 2011 | J Hypertens2011，29，： | 1 |
| 12 | Graft loss among renal-transplant recipients with early reduction of immunosuppression for BK viremia显示文摘AIM To review the incidence of graft loss and acute rejection among renal transplant recipients with early reduction of immunosuppression for BK viremia.METHODS We performed a retrospective analysis of consecutive de-novo kidney-only transplants from January 2009 to December 2012 to evaluate the incidence of Polyomavirus associated nephropathy(PyV AN). Recipient plasma was screened for BKV DNA via quantitative polymerase chain reaction(PCR) at months 1,3,6,9 and 12 post-transplant and on worsening graft function.Immunosuppression was reduced at ≥ 3-log copies/mL. Those with viremia of ≥ 4-log copies/mL(presumptive PyV AN) underwent renal transplant biopsy. Presumptive Py VAN(PP) and definitive Py VAN(DP; biopsy-proven) were treated by immunosuppression reduction(IR) only. RESULTS Among 319 kidney transplant recipients,the median age was 53 years(range 19-83),65.8% were male,and 58.9% were white. Biopsy-proven acute rejection was found in 18.5% within 0-168 wk. Death-censored graft loss occurred in 5.3%(n = 17) and graft loss attributable to PyV AN was 0.6%(n = 2). Forty-seven patients were diagnosed with PP(14.7%) and 18(5.6%) with DP. Graft loss among participants with PyV AN(8.5%) and those without(4.8%) was not significantly different. Deceased donor kidney transplantation(OR = 2.3,95%CI = 1.1-4.6) and AR(OR = 2.3,95%CI = 1.2-4.7) were associated with Py VAN in the multivariate analysis. BK viremia between 3 and 4-log copies/mL occurred in 27 patients,all of whom underwent IR. Of these,16(59%) never developed PyV AN while 11(41%) developed PyV AN(4 DP,7 PP) within a range of 11-39 wk. CONCLUSION Instituting an early reduction of immunosuppression,in the absence of adjunctive antivirals,is effective at preventing PyV AN and may be associated with a lower incidence of graft-loss without a reciprocal increase in the incidence of acute rejection. | Marwan M Azar Roland Assi Aziz K Valika David B Banach Isaac E Hall Marie-Louise Landry Maricar F Malinis | 2017 | World Journal of Transplantation2017，7，5： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员